{"id":"cm4620-ie","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypotension"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL5997929","moleculeType":null,"molecularWeight":"382.26"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inhibiting the L-type calcium channel, which is involved in the regulation of cardiac muscle contraction. This leads to a reduction in cardiac workload and oxygen demand, making it a potential treatment for conditions such as atrial fibrillation.","oneSentence":"CM4620-IE is a small molecule that targets the calcium channel.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:31:23.109Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"}]},"trialDetails":[{"nctId":"NCT04661540","phase":"PHASE2","title":"A Study of Auxora in Patients With Critical COVID-19 Pneumonia","status":"TERMINATED","sponsor":"CalciMedica, Inc.","startDate":"2021-03-02","conditions":"Pneumonia","enrollment":10},{"nctId":"NCT04195347","phase":"PHASE1, PHASE2","title":"Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2020-09-04","conditions":"Acute Pancreatitis","enrollment":42},{"nctId":"NCT04681066","phase":"PHASE2","title":"A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS","status":"COMPLETED","sponsor":"CalciMedica, Inc.","startDate":"2021-03-24","conditions":"Acute Pancreatitis, Systemic Inflammatory Response Syndrome","enrollment":216},{"nctId":"NCT04345614","phase":"PHASE2","title":"A Study of Auxora in Patients With Severe COVID-19 Pneumonia","status":"COMPLETED","sponsor":"CalciMedica, Inc.","startDate":"2020-04-08","conditions":"Pneumonia","enrollment":314},{"nctId":"NCT03709342","phase":"PHASE2","title":"A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis","status":"COMPLETED","sponsor":"CalciMedica, Inc.","startDate":"2019-01-06","conditions":"Acute Pancreatitis","enrollment":7},{"nctId":"NCT03401190","phase":"PHASE2","title":"CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS","status":"COMPLETED","sponsor":"CalciMedica, Inc.","startDate":"2018-03-12","conditions":"Acute Pancreatitis, Systemic Inflammatory Response Syndrome","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CM4620-IE","genericName":"CM4620-IE","companyName":"CalciMedica, Inc.","companyId":"calcimedica-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CM4620-IE is a small molecule that targets the calcium channel. Used for Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}